FARICIMAB
UNII QC4F7FKK7I

Substance Identification & Data

This profile provides standardized clinical and technical data for Faricimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QC4F7FKK7I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1607793-29-2 and the RxNorm Concept ID (RxCUI) 2591519. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QC4F7FKK7I

CAS Registry Number

1607793-29-2

RxNorm Concept ID

2591519

Detailed Substance Profile

Preferred Name

FARICIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

QC4F7FKK7I

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C174885

National Cancer Institute reference terminology for clinical and research data.

INN ID

10563

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-178

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Faricimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FARICIMAB

FARICIMAB-SVOA

Common Names & Synonyms

FARICIMAB [INN]

FARICIMAB [JAN]

FARICIMAB [USAN]

FARICIMAB [WHO-DD]

FARICIMAB SVOA [WHO-DD]

RG-7716

RG-7716 (ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR/ANTI-ANGIOPOIETIN 2 BISPECIFIC ANTIBODY)

Y8HA1I28D3

Brand / Trade Names

VABYSMO

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN ANGIOPOIETIN 2) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LIGHT CHAIN

SYS